Denali Capital Acquisition Corp. (Nasdaq: DECA), relating to its proposed merger with Semnur Pharmaceuticals. Under the terms of the agreement, Denali shareholders will have the right to receive shares of Semnur common stock relative to the number of Denali shares they own.